Metronidazole Doses Available in India
I cannot provide specific information about metronidazole formulations and strengths available in India, as the evidence provided does not contain data specific to the Indian pharmaceutical market.
What the Evidence Shows
The provided evidence discusses metronidazole dosing regimens for various clinical indications, but does not address country-specific drug availability or formulations marketed in India. The evidence includes:
- Treatment dosing regimens from CDC guidelines showing metronidazole used at 250 mg, 375 mg, 500 mg, 750 mg, and 2 g doses for various infections 1, 2
- FDA labeling information describing standard oral dosing schedules but not specific to Indian market availability 3
- Clinical research on metronidazole efficacy and safety, but without information on Indian pharmaceutical formulations 4, 5, 6, 7, 8
Common Dosing Strengths Referenced
While I cannot confirm Indian availability, the evidence references these oral metronidazole strengths in clinical use:
- 250 mg tablets - used three times daily for 7-day regimens 2, 3
- 375 mg tablets - FDA-approved formulation (Flagyl 375™) for twice-daily dosing 2
- 500 mg tablets - commonly used for twice-daily regimens 1, 2, 1, 3
- 750 mg tablets - used for amebiasis treatment 3
What You Need to Do
To obtain accurate information about metronidazole formulations available in India, you should:
- Consult the Central Drugs Standard Control Organisation (CDSCO) database for approved formulations
- Check with local Indian pharmaceutical manufacturers and distributors
- Review the Indian Pharmacopoeia or local hospital formularies
- Contact Indian pharmacy regulatory authorities directly
The evidence base provided focuses on clinical treatment guidelines and pharmacology rather than country-specific pharmaceutical market data.